Researchers at the University of Cambridge have provided the first-ever proof that human nerve regeneration after an injury can be reversed and reactivated. Using stem cell-derived brain and spinal cord organoids, scientists discovered a specific genetic network that acts like a “switch,” shutting down axon growth as neurons mature. Remarkably, by blocking key regulators within this network using an already available human drug called lynestrenol, they successfully retriggered the growth of nerve fibers. While lynestrenol itself is not an immediate cure for spinal cord injuries, this monumental discovery proves that the physiological barrier preventing nerve regeneration can be overcome — opening up incredible new possibilities for reversing paralysis and treating severe neurodegenerative diseases in the future!
Cambridge scientists have grown miniature circuits in the lab that mimic how the brain and spinal cord connect up, which underlies our movements. They used this model to show how damage to these connections previously considered ‘irreversible’ could, in fact, be reversible.
Our sophisticated organoid models help bridge the knowledge gap from animal models to what we see in patients.